Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
doi: 10.3389/fendo.2026.1784709 Received 10 January 2026 Revised 30 January 2026 Accepted 30 January 2026 Published 18 February 2026 Volume 17 - 2026 Edited by Marcia Hiriart, Universidad Nacional Autonoma de Mexico, Mexico Reviewed by Jialin Fan, Rutgers, The State University of New Jersey, United States Kei Shing Ng, The University of Hong Kong, Hong Kong SAR, China Updates Copyright 2026 Liu, Ren, Zhang and Ma
21 and 26 illustrated a substantial elevation in the expression of both VEGF and platelet endothelial cell adhesion molecule-1 (CD31) on day 7 after treatment with G/D-CuP, compared to the negative control and Gel groups
reported that in an IRI mouse model, CEUS-measured renal perfusion significantly decreased after one hour and was negatively correlated with renal function recovery [143]
M.PattersonE.CarafaI.MandalR.WishartD
This is a promising idea in the context of prevention and longevity medicinebut no specific microdosing trials have been conducted to prove it
